Skip to main content
Portfolio
TrendingElectionsPoliticsSportsCultureCryptoCommoditiesClimateEconomicsMentions

Finance

Tech & Science
PredictLive144AccountSocial
MARKETSINVESTLIVE144

Industries

Product
Kalshi ProInvestMarketsIncentive programSmall business hedgingInstitutionsAPI & developers
Company
AboutKalshi ResearchBlogCareersPolicy CenterBrand Kit
Help
Help CenterFAQPrediction marketsFee scheduleTrading hoursRegulatoryTrust Center

© 2026 Kalshi Inc. · All rights reserved
PrivacyData Terms of ServiceTrading ProhibitionsFAQ for Finance Professionals
Trading on Kalshi involves risk and may not be appropriate for all. Members risk losing their cost to enter any transaction, including fees. You should carefully consider whether trading on Kalshi is appropriate for you in light of your investment experience and financial resources. Any trading decisions you make are solely your responsibility and at your own risk. Information is provided for convenience only on an "AS IS" basis. Past performance is not necessarily indicative of future results. Kalshi is subject to U.S. regulatory oversight by the CFTC.
All markets (715)
15 min (10)
Hourly (9)
Daily (11)
Weekly (14)
Monthly (53)
Annual (20)

Public Companies Hub
Indices
Foreign Exchange
Interest Rates
Company metrics
Company news
Industries
Biotech
Advertising Spend
Real Estate
Sector Trends
Technology
Match Ups
Black Friday

Financials odds and guides

IPO odds for every companyStock market predictions: S&P 500 and Nasdaq-100

Venice, CA home values in November

$2,035,000
--
$2.05 million
--
$0 vol

FDA decision: Vamikibart by Genentech (on or before July 31, 2027)

Yes
--
No
--
$0 vol

FDA decision: Ulixacaltamide by Praxis Precision Medicines (on or before January 29, 2027)

Yes
--
No
1.01x
$0 vol

FDA decision: Tozorakimab by AstraZeneca (on or before March 31, 2027)

Yes
--
No
1.01x
$0 vol

Seattle, WA home values in November

$905,000
18.8x
$875,000
--
$0 vol

San Diego, CA home values in November

$1.12 million
--
$1,115,000
--
$0 vol

FDA decision: Saroglitazar by Zydus Therapeutics (this year)

Yes
1.01x
No
1.01x
$1 vol

Santa Monica, CA home values in November

$2,655,000
--
$2.67 million
--
$0 vol

FDA decision: Ralinepag by United Therapeutics (on or before June 24, 2027)

Yes
--
No
--
$0 vol

Phoenix, AZ home values in November

$412,000
--
$414,000
--
$0 vol

Philadelphia, PA home values in November

$224,250
--
$224,750
--
$0 vol

Palo Alto, CA home values in November

$3.86 million
--
$3.91 million
--
$0 vol

Pacific Palisades, CA home values in November

$3.25 million
--
$3.28 million
--
$0 vol

New York, NY home values in November

$872,500
--
$875,000
--
$0 vol

Miami, FL home values in November

$662,500
--
$665,000
--
$0 vol

Memphis, TN home values in December

Above $140,000
--
Above $145,000
--
$0 vol

FDA decision: Lorundrostat by Mineralys Therapeutics (on or before December 22, 2026)

Yes
--
No
--
$0 vol

Los Angeles, CA home values in November

$1,002,500
--
$1.01 million
--
$0 vol

Jersey City, NJ home values in November

$660,000
--
$661,000
--
$0 vol

Houston, TX condo values in February 2027

Below $111,000
--
Below $114,000
--
$0 vol

Hoboken, NJ home values in November

$1,207,500
--
$1.2 million
--
$0 vol

Dallas, TX home values in November

$321,000
23.4x
$316,000
--
$0 vol

Chicago, IL home values in November

$333,750
5.90x
$334,000
--
$0 vol

FDA decision: BBP-418 by Ml Bio Solutions Inc. (this year)

Yes
1.02x
No
1.01x
$3 vol